Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Drug Screening Market

Drug Screening Market Share

Report ID: GMI5971
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Drug Screening Market Share

Major market players operating in the drug screening market include :

Laboratory Corporation of America
Quest Diagnostics
Abbott Laboratories
OraSure Technologies, Inc.
Alfa Scientific Designs, Inc.
Thermo Fisher Scientific Inc.
Drägerwerk AG & Co. KGaA
Lifeloc Technologies, Inc.
Omega Laboratories, Inc.
Premier Biotech, Inc.
Psychemedics Corporation
F.Hoffmann-La Roche Ltd
Shimadzu Scientific Instruments.
Siemens Healthineers

These industry players majorly adopt various strategies including collaborations, acquisitions, mergers, and partnerships to create a global footprint and sustain market competition.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for drug screening was USD 6.2 billion in 2022 and will reach USD 27.1 billion by 2032.

Drug screening products market share was 55.7% in 2022 attributed to the increasing launch of advanced drug screening products that provide improved solutions to make testing easy, accurate, and fast.

North America is expected to hold a significant share of the drug screening market between 2023 and 2032 due to the adverse issue of high levels of alcohol intake in the region.

Laboratory Corporation of America, Quest Diagnostics, OraSure Technologies, Inc., Thermo Fisher Scientific Inc., Lifeloc Technologies, Inc., Psychemedics Corporation, F. Hoffmann-La Roche Ltd, Siemens Healthineers, and Omega Laboratories, Inc. among others.